Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


August 02, 2015 12:41 AM ET

Pharmaceuticals

Company Overview of Avexa Ltd.

Executive Profile

Joep Lange M.D., Ph.D.

Member of Scientific Advisory Board, Avexa Ltd.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 3 different industries.

See Board Relationships
----

Background

Dr. Joep Lange, M.D., Ph.D., serves as the Professor of Internal Medicine and Director of Academic Medical Center of National AIDS Therapy Evaluation Center, Amsterdam, The Netherlands. He serves as Senior Scientific Advisor of International Antiviral Therapy Evaluation Centre. He serves as a Co-Chairman of HIV Scientific Advisory Board at Idenix Pharmaceuticals Inc. He served as the Chief of the World Health Organization's Clinical Research and Product Development branch ...

Corporate Headquarters

61-63 Camberwell Road
Hawthorn East, Victoria 3123

Australia

Phone: 61 3 8888 1040
Fax: --

Board Members Memberships

There is no Board Members Memberships data available.

Education

There is no Education data available.

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Giovanni Caforio M.D.Chief Executive Officer and Director
Bristol-Myers Squibb Company
$916.0K
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Kenneth C. Frazier Chairman, Chief Executive Officer and President
Merck & Co. Inc.
$1.5M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Avexa Ltd., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.